76
|
Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, Yarchoan M, Chen J, Voltaggio L, Parian A, Lazarev M, Lauwers GY, Pawlik TM, Montgomery EA, Jaffee E, Le DT, Taube JM, Anders RA. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. J Intern Med 2018; 283:568-577. [PMID: 29464806 PMCID: PMC5992029 DOI: 10.1111/joim.12744] [Citation(s) in RCA: 65] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND Use of the immune checkpoint inhibitor ipilimumab is sometimes complicated by ipilimumab-associated colitis (Ipi-AC), an immune-mediated colitis that mimics inflammatory bowel disease. OBJECTIVE We sought to characterize the histopathologic and immunophenotypic features of Ipi-AC and to directly compare these features to ulcerative colitis (UC). METHODS This is a retrospective cohort study of 22 patients with Ipi-AC, 12 patients with treatment-naïve UC and five controls with diarrhoea but normal endoscopic findings. Immunohistopathologic features were described, and quantitative immunohistochemistry (IHC) was performed for CD4, CD8, CD20, CD138 and FOXP3. RESULTS Endoscopic findings in both the Ipi-AC and UC groups included ulcerated, oedematous and erythematous mucosa. Involvement of the GI tract was more diffuse in Ipi-AC. As compared to UC, a smaller proportion of Ipi-AC biopsies had basal plasmacytosis (14% for Ipi-AC vs. 92% for UC, P < 0.0001) and crypt distortion (23% for Ipi-AC vs. 75% for UC, P = 0.003), whereas Ipi-AC biopsies had more apoptotic bodies in the left colon (17.6 ± 15.3 for Ipi-AC vs. 8.2 ± 4.2 for UC, P = 0.011). Cryptitis, ulcerations and crypt abscesses were common in both groups. Biopsy specimens from Ipi-AC had a lower density of CD20-positive lymphocytes than UC (275.8 ± 253.3 cells mm-2 for Ipi-AC vs. 1173.3 ± 1158.2 cells mm-2 for UC, P = 0.022) but had a similar density of CD4, CD8, CD138 and FOXP3-positive cells. CONCLUSIONS Ipi-AC is a distinct pathologic entity with notable clinical and histopathological differences compared to UC. These findings provide insights into the pathophysiology of immune-related adverse events (iAEs) from ipilimumab therapy.
Collapse
|
77
|
Kim A, Berens P, Chen H, Gants S, Sliwinski L, Chang-Jackson S. The trend, feasibility, and safety of salpingectomy as a form of permanent sterilization. Gynecol Oncol 2018. [DOI: 10.1016/j.ygyno.2018.04.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
78
|
Zaidat OO, Bozorgchami H, Ribó M, Saver JL, Mattle HP, Chapot R, Narata AP, Francois O, Jadhav AP, Grossberg JA, Riedel CH, Tomasello A, Clark WM, Nordmeyer H, Lin E, Nogueira RG, Yoo AJ, Jovin TG, Siddiqui AH, Bernard T, Claffey M, Andersson T, Ribo M, Hetts S, Hacke W, Mehta B, Hacein-Bey L, Kim A, Abou-Chebl A, Shabe P, Hetts S, Hacein-Bey L, Kim A, Abou-Chebl A, Dix J, Gurian J, Zink W, Dabus G, O’Leary, N, Reilly A, Lee K, Foley J, Dolan M, Hartley E, Clark T, Nadeau K, Shama J, Hull L, Brown B, Priest R, Nesbit G, Horikawa M, Hoak D, Petersen B, Beadell N, Herrick K, White C, Stacey M, Ford S, Liu J, Ribó M, Sanjuan, E, Sanchis M, Molina C, Rodríguez-Luna, D, Boned Riera S, Pagola J, Rubiera M, Juega J, Rodríguez N, Muller N, Stauder M, Stracke P, Heddier M, Charron V, Decock A, Herbreteau D, Bibi R, De Sloovere A, Doutreloigne I, Pieters D, Dewaele T, Bourgeois P, Vanhee F, Vanderdouckt P, Vancaster E, Baxendell L, Gilchrist V, Cannon Y, Graves C, Armbruster K, Jovin T, Jankowitz B, Ducruet A, Aghaebrahim A, Kenmuir C, Shoirah H, Molyneaux B, Tadi P, Walker G, Starr M, Doppelheuer S, Schindler K, Craft L, Schultz M, Perez H, Park J, Hall A, Mitchell A, Webb L, Haussen D, Frankel M, Bianchi N, Belagaje S, Mahdi N, Lahoti S, Katema A, Winningham M, Anderson A, Tilley D, Steinhauser T, Scott D, Thacker A, Calderon V, Lin E, Becke S, Krieter S, Jansen O, Wodarg F, Larsen N, Binder A, Wiesen C, Hartney M, Bookhagan L, Ross H, Gay J, Snyder K, Levy E, Davies J, Sonig A, Rangel-Castilla L, Mowla A, Shakir H, Fennell V, Atwal G, Natarajan S, Beecher J, Thornton J, Cullen A, Brennan P, O’Hare A, Asadi H, Budzik R, Taylor M, Jennings M, Laube F, Jackson J, Gatrell R, Reebel L, Albon A, Gerniak J, Groezinger K, Lauf M, Voraco N, Pema P, Davis T, Hicks W, Mejilla J, Teleb M, Sunenshine P, Russo E, Flynn R, Twyford J, Ver Hage A, Smith E, Apolinar L, Blythe S, Maxan J, Carter J, Taschner T, Bergmann U, Meckel S, Elsheik S, Urbach H, Maurer C, Egger K, Niesen W, Baxter B, Knox, A, Hazelwood B, Quarfordt S, Calvert J, Hawk H, Malek, R, Padidar A, Tolley U, Gutierrez A, Mordasini P, Seip T, Balasubramaniam R, Gralla J, Fischer U, Zibold F, Piechowiak E, DeLeacy R, Apruzzeses R, Alfonso C, Haslett J, Fifi J, Mocco J, Starkman S, Guzy, J, Grunberg N, Szeder V, Tateshima S, Duckwiler G, Nour M, Liebeskind D, Tang X, Hinman J, Tipirneni A, Yavagal D, Guada L, Bates K, Balladeras S, Bokka S, Suir S, Caplan J, Kandewall P, Peterson E, Starke R, Puri A, Hawk M, Brooks C, L’Heurex J, Ty K, Rex D, Massari F, Wakhloo A, Lozano D, Rodrigua K, Pierot L, Fabienne M, Sebastien S, Emmoinoli M. Primary Results of the Multicenter ARISE II Study (Analysis of Revascularization in Ischemic Stroke With EmboTrap). Stroke 2018; 49:1107-1115. [DOI: 10.1161/strokeaha.117.020125] [Citation(s) in RCA: 92] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2017] [Revised: 02/05/2018] [Accepted: 02/26/2018] [Indexed: 02/04/2023]
|
79
|
Kim J, Lee J, Kim A, Jeon J, Oh C, Seo S, Kim I, Krueger J. 888 β-Defensin 103 characterizes a distinct molecular phenotype of human acral melanoma, by its correlated expression with IL-17A & IFNγ-mediated immune genes, as well as MC1R-mediated pigmentation signatures. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
80
|
Pavlus J, Sandow T, Cohen E, Caridi T, Lynskey G, Buckley D, Cardella J, Field D, Spies J, Kim A. 3:27 PM Abstract No. 134 Is smaller better for hepatocellular carcinoma? Evaluation of DEB-TACE bead size and cTACE in 142 explanted tumors. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
81
|
Chowdhury S, Ertreo M, An J, Lynskey G, Caridi T, Cohen E, Cardella J, Field D, Buckley D, Spies J, Kim A. 3:36 PM Abstract No. 85 Pretreatment 99m Tc-mebrofenin hepatobiliary scintigraphy, an adjuvant predictor of post-radioembolization clinical status. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
82
|
Sandow T, Pavlus J, Caridi T, Lynskey G, Buckley D, Field D, Cardella J, Cohen E, Spies J, Kim A. 3:54 PM Abstract No. 278 Predicting recurrence prior to transplant: the response of hepatocellular carcinoma to chemoembolization in a 12-year transplant cohort. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
83
|
Kim A, Frantz S, Brower J, Akhter N. 3:18 PM Abstract No. 263 Multicenter evaluation of yttrium-90 selective internal radiation therapy for the treatment of metastatic pancreatic adenocarcinoma. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
84
|
Sandow T, Pavlus J, Caridi T, Lynskey G, Buckley D, Cardella J, Field D, Cohen E, Spies J, Kim A. 3:18 PM Abstract No. 273 AFP-negative hepatocellular carcinoma identifies tumors with better post-TACE necrosis rates at liver explant: evaluation of 83 patients in a 7-year transplant cohort. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
85
|
Kapoor B, Contreras F, Katz M, Arepally A, Fischman A, Rose S, Kim A, Ferraro J. 3:18 PM Abstract No. 133 Surefire Infusion System (SIS) hepatocellular carcinoma registry study interim results: a multicenter study of the safety, feasibility, and outcomes of the SIS expandable-tip microcatheter in DEB-TACE. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
86
|
Stirnemann J, Djaafri F, Kim A, Mediouni I, Bussieres L, Spaggiari E, Veluppillai C, Lapillonne A, Kermorvant E, Magny JF, Colmant C, Ville Y. Preterm premature rupture of membranes is a collateral effect of improvement in perinatal outcomes following fetoscopic coagulation of chorionic vessels for twin-twin transfusion syndrome: a retrospective observational study of 1092 cases. BJOG 2018; 125:1154-1162. [DOI: 10.1111/1471-0528.15147] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/23/2018] [Indexed: 11/29/2022]
|
87
|
Korpal M, Puyang X, Furman C, Zheng GZ, Banka D, Wu J, Zhang Z, Thomas M, Mackenzie C, Yao H, Rimkunas V, Kumar P, Caleb B, Karr C, Subramanian V, Irwin S, Larsen N, Vaillancourt F, Nguyen TV, Davis A, Chan B, Hao MH, O'Shea M, Prajapati S, Agoulnik S, Kuznetsov G, Kumar N, Yu Y, Lai G, Hart A, Eckley S, Fekkes P, Bowser T, Joshi JJ, Selvaraj A, Wardell S, Norris J, Smith S, Reynolds D, Mitchell L, Wang J, Yu L, Kim A, Rioux N, Sahmoud T, Warmuth M, Smith PG, Zhu P. Abstract P1-10-08: Development of a first-in-class oral selective ERα covalent antagonist (SERCA) for the treatment of ERαWT and ERαMUT breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p1-10-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Mutations in estrogen receptor alpha (ERα) are detected in up to 30% of breast cancer patients who have relapsed during endocrine therapy. ERα mutations functionally confer resistance to existing classes of endocrine therapies, likely through gaining constitutive activity. The fact that current ER-directed therapies are only partially effective in the ERα mutant setting, and that a significant proportion of resistant breast cancer metastases continue to remain dependent on ERα signaling for growth/survival, highlights the critical need to develop the next generation of ERα antagonists that can overcome aberrant ERα activity. Using structure-based drug design approaches we have identified a novel class of ERα antagonist referred to as Selective ERα Covalent Antagonist (SERCA) that inactivate both wild-type and mutant ERα by targeting a unique cysteine residue that is not conserved among other steroid hormone receptors. Biophysical, biochemical and cellular analyses confirm the covalent mechanism of action, specific binding to ER and selective inhibition of ERα-dependent transcription of SERCAs. H3B-6545 is a highly selective SERCA that potently antagonizes wild-type and mutant ERα in biochemical and cell based assays demonstrating increased potency over standard of care and other experimental agents. In vivo, H3B-6545 shows superior efficacy to fulvestrant in the MCF-7 xenograft model with once daily oral dosing, achieving maximal antitumor activity at doses >10x below the maximum tolerated dose in mice. In addition, H3B-6545 shows superior antitumor activity to both tamoxifen and fulvestrant in patient derived xenograft models of breast cancer carrying estrogen receptor mutations. In summary, H3B-6545 is a first-in-class, orally available and selective ER covalent antagonist with a compelling pre-clinical profile that is being developed for the treatment of ERα positive breast cancer.
Citation Format: Korpal M, Puyang X, Furman C, Zheng GZ, Banka D, Wu J, Zhang Z, Thomas M, Mackenzie C, Yao H, Rimkunas V, Kumar P, Caleb B, Karr C, Subramanian V, Irwin S, Larsen N, Vaillancourt F, Nguyen T-V, Davis A, Chan B, Hao MH, O'Shea M, Prajapati S, Agoulnik S, Kuznetsov G, Kumar N, Yu Y, Lai G, Hart A, Eckley S, Fekkes P, Bowser T, Joshi JJ, Selvaraj A, Wardell S, Norris J, Smith S, Reynolds D, Mitchell L, Wang J, Yu L, Kim A, Rioux N, Sahmoud T, Warmuth M, Smith PG, Zhu P. Development of a first-in-class oral selective ERα covalent antagonist (SERCA) for the treatment of ERαWT and ERαMUT breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P1-10-08.
Collapse
|
88
|
Shimizu H, Kahl D, Yamaguchi H, Abe K, Beliuskina O, Cha SM, Chae KY, Chen AA, Ge Z, Hayakawa S, Imai N, Iwasa N, Kim A, Kim DH, Kim MJ, Kubono S, Kawag MS, Liang J, Moon JY, Nishimura S, Oka S, Park SY, Psaltis A, Teranishi T, Ueno Y, Yang L. Isomeric 26Al beam production with CRIB. EPJ WEB OF CONFERENCES 2018. [DOI: 10.1051/epjconf/201818402013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
We performed an experiment to measure proton resonant elastic scattering of a mixed 26m,gAl beam with a thick target in inverse kinematics by using CNS RI beam sep-arator, located at RIKEN Nishina Center. It aimed to search for strong proton resonances and determine level properties of low spin-parity states in 27Si. Diagnosis of the 26mAl purity of the beam by annihilation radiation are discussed.
Collapse
|
89
|
Ugrumov M, Kolacheva A, Kim A, Khakimova G, Nigmatullina R, Zalyalova Z, Georgieva S, Kudrin V. Novel paradigm for the development of preclinical diagnosis of Parkinson’s disease based on searching blood markers and a provocation test. Parkinsonism Relat Disord 2018. [DOI: 10.1016/j.parkreldis.2017.11.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
90
|
Mishra A, Nam GH, Gim JA, Lee HE, Jo A, Yoon D, Oh S, Kim S, Kim A, Kim DH, Kim YC, Jeong HD, Cha HJ, Choi YH, Kim HS. Comparative evaluation of MCP gene in worldwide strains of Megalocytivirus (Iridoviridae family) for early diagnostic marker. JOURNAL OF FISH DISEASES 2018; 41:105-116. [PMID: 28914452 DOI: 10.1111/jfd.12685] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/04/2017] [Revised: 06/18/2017] [Accepted: 06/19/2017] [Indexed: 06/07/2023]
Abstract
Members of the Iridoviridae family have been considered as aetiological agents of iridovirus diseases, causing fish mortalities and economic losses all over the world. Virus identification based on candidate gene sequencing is faster, more accurate and more reliable than other traditional phenotype methodologies. Iridoviridae viruses are covered by a protein shell (capsid) encoded by the important candidate gene, major capsid protein (MCP). In this study, we investigated the potential of the MCP gene for use in the diagnosis and identification of infections caused Megalocytivirus of the Iridoviridae family. We selected data of 66 Iridoviridae family isolates (53 strains of Megalocytivirus, eight strains of iridoviruses and five strains of Ranavirus) infecting various species of fish distributed all over the world. A total of 53 strains of Megalocytivirus were used for designing the complete primer sets for identifying the most hypervariable region of the MCP gene. Further, our in silico analysis of 102 sequences of related and unrelated viruses reconfirms that primer sets could identify strains more specifically and offers a useful and fast alternative for routine clinical laboratory testing. Our findings suggest that phenotype observation along with diagnosis using universal primer sets can help detect infection or carriers at an early stage.
Collapse
|
91
|
Hattawy M, Baltzell NA, Dupré R, Hafidi K, Stepanyan S, Bültmann S, De Vita R, El Alaoui A, El Fassi L, Egiyan H, Girod FX, Guidal M, Jenkins D, Liuti S, Perrin Y, Torayev B, Voutier E, Adhikari KP, Adhikari S, Adikaram D, Akbar Z, Amaryan MJ, Anefalos Pereira S, Armstrong WR, Avakian H, Ball J, Bashkanov M, Battaglieri M, Batourine V, Bedlinskiy I, Biselli AS, Boiarinov S, Briscoe WJ, Brooks WK, Burkert VD, Thanh Cao F, Carman DS, Celentano A, Charles G, Chetry T, Ciullo G, Clark L, Colaneri L, Cole PL, Contalbrigo M, Cortes O, Crede V, D'Angelo A, Dashyan N, De Sanctis E, Deur A, Djalali C, Elouadrhiri L, Eugenio P, Fedotov G, Fegan S, Fersch R, Filippi A, Fleming JA, Forest TA, Fradi A, Garçon M, Gevorgyan N, Ghandilyan Y, Gilfoyle GP, Giovanetti KL, Gleason C, Gohn W, Golovatch E, Gothe RW, Griffioen KA, Guo L, Hakobyan H, Hanretty C, Harrison N, Heddle D, Hicks K, Holtrop M, Hughes SM, Ireland DG, Ishkhanov BS, Isupov EL, Jiang H, Joo K, Joosten S, Keller D, Khachatryan G, Khachatryan M, Khandaker M, Kim A, Kim W, Klein A, Klein FJ, Kubarovsky V, Kuhn SE, Kuleshov SV, Lanza L, Lenisa P, Livingston K, Lu HY, MacGregor IJD, Markov N, Mayer M, McCracken ME, McKinnon B, Meyer CA, Meziani ZE, Mineeva T, Mirazita M, Mokeev V, Montgomery RA, Moutarde H, Movsisyan A, Munoz Camacho C, Nadel-Turonski P, Net LA, Niccolai S, Niculescu G, Niculescu I, Osipenko M, Ostrovidov AI, Paolone M, Paremuzyan R, Park K, Pasyuk E, Phelps E, Phelps W, Pisano S, Pogorelko O, Price JW, Prok Y, Protopopescu D, Ripani M, Ritchie BG, Rizzo A, Rosner G, Rossi P, Sabatié F, Salgado C, Schumacher RA, Seder E, Sharabian YG, Simonyan A, Skorodumina I, Smith GD, Sokhan D, Sparveris N, Strauch S, Taiuti M, Ungaro M, Voskanyan H, Walford NK, Watts DP, Wei X, Weinstein LB, Wood MH, Zachariou N, Zana L, Zhang J, Zhao ZW. First Exclusive Measurement of Deeply Virtual Compton Scattering off ^{4}He: Toward the 3D Tomography of Nuclei. PHYSICAL REVIEW LETTERS 2017; 119:202004. [PMID: 29219329 DOI: 10.1103/physrevlett.119.202004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2017] [Indexed: 06/07/2023]
Abstract
We report on the first measurement of the beam-spin asymmetry in the exclusive process of coherent deeply virtual Compton scattering off a nucleus. The experiment uses the 6 GeV electron beam from the Continuous Electron Beam Accelerator Facility (CEBAF) accelerator at Jefferson Lab incident on a pressurized ^{4}He gaseous target placed in front of the CEBAF Large Acceptance Spectrometer (CLAS). The scattered electron is detected by CLAS and the photon by a dedicated electromagnetic calorimeter at forward angles. To ensure the exclusivity of the process, a specially designed radial time projection chamber is used to detect the recoiling ^{4}He nuclei. We measure beam-spin asymmetries larger than those observed on the free proton in the same kinematic domain. From these, we are able to extract, in a model-independent way, the real and imaginary parts of the only ^{4}He Compton form factor, H_{A}. This first measurement of coherent deeply virtual Compton scattering on the ^{4}He nucleus, with a fully exclusive final state via nuclear recoil tagging, leads the way toward 3D imaging of the partonic structure of nuclei.
Collapse
|
92
|
Kim D, Kim H, Sohn S, Kim A, Baek S, Lee C, Jeong I, Kim T. 688 Epithelial precursor cell-conditioned media ameliorates UV irradiation-induced extracellular matrix damage in human skin equivalents. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
93
|
Kim A, Choi J, Lee R. Non-invasive brain imaging biomarkers in sudden unexpected death in epilepsy patients (SUDEP). J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
94
|
Kim A. RECONCILING INTERGENERATIONAL AMBIVALENCE AND ONWARD TO INTIMATE JAPANESE AND KOREAN FATHERING. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
95
|
Ho D, Peng P, Bass C, Collins P, D'Angelo A, Deur A, Fleming J, Hanretty C, Kageya T, Khandaker M, Klein FJ, Klempt E, Laine V, Lowry MM, Lu H, Nepali C, Nikonov VA, O'Connell T, Sandorfi AM, Sarantsev AV, Schumacher RA, Strakovsky II, Švarc A, Walford NK, Wei X, Whisnant CS, Workman RL, Zonta I, Adhikari KP, Adikaram D, Akbar Z, Amaryan MJ, Anefalos Pereira S, Avakian H, Ball J, Bashkanov M, Battaglieri M, Batourine V, Bedlinskiy I, Biselli A, Briscoe WJ, Burkert VD, Carman DS, Celentano A, Charles G, Chetry T, Ciullo G, Clark L, Colaneri L, Cole PL, Contalbrigo M, Crede V, Dashyan N, De Sanctis E, De Vita R, Djalali C, Dupre R, El Alaoui A, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Fegan S, Fersch R, Filippi A, Fradi A, Ghandilyan Y, Gilfoyle GP, Girod FX, Glazier DI, Gleason C, Gohn W, Golovatch E, Gothe RW, Griffioen KA, Guidal M, Guo L, Hakobyan H, Harrison N, Hattawy M, Hicks K, Holtrop M, Hughes SM, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Jenkins D, Jiang H, Jo HS, Joo K, Joosten S, Keller D, Khachatryan G, Kim A, Kim W, Klein A, Kubarovsky V, Kuleshov SV, Lanza L, Lenisa P, Livingston K, MacGregor IJD, Markov N, McKinnon B, Mineeva T, Mokeev V, Montgomery RA, Movsisyan A, Munoz Camacho C, Murdoch G, Niccolai S, Niculescu G, Osipenko M, Paolone M, Paremuzyan R, Park K, Pasyuk E, Phelps W, Pogorelko O, Price JW, Procureur S, Protopopescu D, Ripani M, Riser D, Ritchie BG, Rizzo A, Rosner G, Sabatié F, Salgado C, Sharabian YG, Skorodumina I, Smith GD, Sober DI, Sokhan D, Sparveris N, Strauch S, Tian Y, Torayev B, Ungaro M, Voskanyan H, Voutier E, Watts DP, Wood MH, Zachariou N, Zhang J, Zhao ZW. Beam-Target Helicity Asymmetry for γ[over →]n[over →]→π^{-}p in the N^{*} Resonance Region. PHYSICAL REVIEW LETTERS 2017; 118:242002. [PMID: 28665642 DOI: 10.1103/physrevlett.118.242002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/07/2017] [Indexed: 06/07/2023]
Abstract
We report the first beam-target double-polarization asymmetries in the γ+n(p)→π^{-}+p(p) reaction spanning the nucleon resonance region from invariant mass W=1500 to 2300 MeV. Circularly polarized photons and longitudinally polarized deuterons in solid hydrogen deuteride (HD) have been used with the CEBAF Large Acceptance Spectrometer (CLAS) at Jefferson Lab. The exclusive final state has been extracted using three very different analyses that show excellent agreement, and these have been used to deduce the E polarization observable for an effective neutron target. These results have been incorporated into new partial wave analyses and have led to significant revisions for several γnN^{*} resonance photocouplings.
Collapse
|
96
|
Tchistiakova E, Kim A, Song WY, Pang G. MR-safe personal radiation dosimeters. J Appl Clin Med Phys 2017; 18:180-184. [PMID: 28585406 PMCID: PMC5874943 DOI: 10.1002/acm2.12115] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Revised: 04/12/2017] [Accepted: 04/20/2017] [Indexed: 11/24/2022] Open
Abstract
Magnetic resonance imaging (MRI) is being rapidly integrated for cancer treatments—such systems are referred to as MRI‐guided radiation therapy (MRIgRT). As the magnet of an MRI scanner is always on, the presence of a strong static magnetic field from the MRI scanner during radiotherapy delivery presents new challenges. One of the challenges is that a personal radiation dosimeter used to estimate the radiation dose deposited in an individual wearing the device must be MR‐safe. No such devices, however, are currently available. In this work we first modified an existing personal dosimeter (by removing a metal clip) to make it MR‐safe and then investigated potential effects of magnetic field on dosimeter readings, i.e., optically stimulated luminescent dosimeter (OSLD) readings. We found that the effect of magnetic field on OSLD sensitivity was within radiation protection tolerance levels. OSLD personal dosimeters can be directly used in conjunction with MRIgRT radiation protection purposes.
Collapse
|
97
|
Shin DG, Kim TH, Jeong H, Kim A, Uhm JS, Joung B, Lee MH, Pak HN. P323Prognostic value of inferior shift of P-wave axis after catheter ablation for longstanding persistent atrial fibrillation including anterior line. Europace 2017. [DOI: 10.1093/ehjci/eux141.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
98
|
Gao S, Kim A, Puchalski J, Bramley K, Detterbeck F, Boffa D, Decker R. Indications for Invasive Mediastinal Staging in Patients with Early Non–Small Cell Lung Cancer Staged with Positron Emission Tomography-Computed Tomography. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.01.061] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
99
|
Kim A, Boronina TN, Cole RN, Darrah E, Sadegh-Nasseri S. Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing. Sci Rep 2017; 7:46418. [PMID: 28422163 PMCID: PMC5396073 DOI: 10.1038/srep46418] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2016] [Accepted: 03/15/2017] [Indexed: 11/09/2022] Open
Abstract
The immune system focuses on and responds to very few representative immunodominant epitopes from pathogenic insults. However, due to the complexity of the antigen processing, understanding the parameters that lead to immunodominance has proved difficult. In an attempt to uncover the determinants of immunodominance among several dominant epitopes, we utilized a cell free antigen processing system and allowed the system to identify the hierarchies among potential determinants. We then tested the results in vivo; in mice and in human. We report here, that immunodominance of known sequences in a given protein can change if two or more proteins are being processed and presented simultaneously. Surprisingly, we find that new spacer/tag sequences commonly added to proteins for purification purposes can distort the capture of the physiological immunodominant epitopes. We warn against adding tags and spacers to candidate vaccines, or recommend cleaving it off before using for vaccination.
Collapse
|
100
|
Olson C, Rochau G, Slutz S, Morrow C, Olson R, Cuneo M, Hanson D, Bennett G, Sanford T, Bailey J, Stygar W, Vesey R, Mehlhorn T, Struve K, Mazarakis M, Savage M, Pointon T, Kiefer M, Rosenthal S, Cochrane K, Schneider L, Glover S, Reed K, Schroen D, Farnum C, Modesto M, Oscar D, Chhabildas L, Boyes J, Vigil V, Keith R, Turgeon M, Cipiti M, Lindgren E, Dandini V, Tran H, Smith D, McDaniel D, Quintenz J, Matzen MK, VanDevender JP, Gauster W, Shephard L, Walck M, Renk T, Tanaka T, Ulrickson M, Meier W, Latkowski J, Moir R, Schmitt R, Reyes S, Abbott R, Peterson R, Pollock G, Ottinger P, Schumer J, Peterson P, Kammer D, Kulcinski G, El-Guebaly L, Moses G, Sviatoslavsky I, Sawan M, Anderson M, Bonazza R, Oakley J, Meekunasombat P, De Groot J, Jensen N, Abdou M, Ying A, Calderoni P, Morley N, Abdel-Khalik S, Dillon C, Lascar C, Sadowski D, Curry R, McDonald K, Barkey M, Szaroletta W, Gallix R, Alexander N, Rickman W, Charman C, Shatoff H, Welch D, Rose D, Panchuk P, Louie D, Dean S, Kim A, Nedoseev S, Grabovsky E, Kingsep A, Smirnov V. Development Path for Z-Pinch IFE. FUSION SCIENCE AND TECHNOLOGY 2017. [DOI: 10.13182/fst05-a757] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|